Clinical trial
Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events (IDEAL-Study)
NCT01417949 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events (IDEAL-Study)
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2011
- Completion date
- May 31, 2015
- Enrollment
- 61 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
hiv-infection